The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORM.L Regulatory News (ORM)

  • There is currently no data for ORM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Acquisition

6 Apr 2021 14:43

RNS Number : 5494U
Ormonde Mining PLC
06 April 2021
 

This announcement contains inside information

 

6 April 2021

 

Ormonde Mining plc

("Ormonde" or "the Company")

 

Business development update

 

 

On 16 September 2020, the Company announced that it had entered into an exclusivity agreement in relation to the proposed acquisition of a majority stake in certain copper mining licenses (the "Licenses") in the Republic of the Congo ("Proposed Transaction"), and the Company gave further details in relation to the Proposed Transaction and the Licenses in an announcement on 14 January 2021. Since that time, the Company has been working to advance negotiations against the backdrop of a global pandemic and a presidential election in the Republic of the Congo, both of which resulted in delays to the process.

 

However, following the most recent AGM of the Company, Ormonde is no longer authorised to issue shares for a transaction of this nature without a further shareholder approval process (see announcement of 18 February 2021), which introduced an increased level of uncertainty and execution risk for the counterparties. Ultimately the counterparties demanded more onerous terms for the Proposed Transaction, which significantly impacted the accretive potential of the Proposed Transaction for all Ormonde shareholders. This was unacceptable to the Company and a suitable compromise could not be agreed. As a result, all discussions have been terminated.

 

The Board of the Company believed that the Proposed Transaction represented a transformative acquisition for Ormonde, focused on minimising share dilution and execution risk for Ormonde shareholders. The Board of the Company will continue to adopt this approach in its review of other suitable opportunities. However, the Company also recognises the future requirement to gain shareholder authorisation to issue shares, the uncertainty of which may limit the ability to engage in discussions requiring a share-based transaction. The Board will also now explore alternative strategies for the business in the interest of all shareholders. The Company will keep the market appraised as work continues towards sourcing a value accretive transaction or an alternative course for the Company.

 

Commenting on these developments, Jonathan Henry, Executive Chair, stated:

 

"The proposed transaction, which Ormonde has spent considerable time and effort in trying to complete, was an exceptional opportunity for the Company. Regrettably, the Company has been unable to finalise binding terms agreeable to all parties and we therefore have had no choice but to concentrate our resources elsewhere. Management is now working with the Board to review a number of other transactions for the business or alternative strategies, which could deliver shareholder value and reward our shareholders for the patience shown to date."

 

Enquiries to:

 

Ormonde Mining plc

Jonathan Henry, Executive Chair

Paul Carroll, Chief Financial Officer

Fraser Gardiner, Chief Operating Officer

Tel: +353 (0)1 8014184

 

Buchanan

Bobby Morse / Ariadna Peretz / James Husband

Tel: +44 (0)20 7466 5000

Email: ormonde@buchanan.uk.com 

 

 

Davy (Nomad, Euronext Growth Advisor and Joint Broker)

John Frain / Barry Murphy

Tel: +353 (0)1 679 6363

 

SP Angel Corporate Finance LLP (Joint Broker)

Ewan Leggat

Tel: +44 (0)20 3 470 0470

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEADLKELFFEFA
Date   Source Headline
5th Sep 20237:00 amRNSTrading on Aquis Growth Market
5th Sep 20237:00 amRNSCancellation - ORMONDE MINING PLC
4th Sep 20238:28 amRNSAdmission to Aquis Growth Market
25th Aug 20233:33 pmRNSResult of EGM & AGM
31st Jul 20236:26 pmRNSNotice of EGM & AGM
27th Jul 20236:19 pmRNSProposed Cancellation of Trading on AIM & Euronext
30th Jun 20236:27 pmRNSInvestment in TRU Precious Metals Corp.
27th Jun 20236:20 pmRNSFinal Results
8th Feb 20236:00 pmRNSOrmonde Mining
7th Feb 20237:30 amRNSSuspension - Ormonde Mining plc
7th Feb 20237:00 amRNSInvestment & Suspension of Listing
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Oct 202211:11 amRNSCompletion of Sale of La Zarza Assets
28th Sep 20221:15 pmRNSResult of AGM & EGM
28th Sep 20227:00 amRNSHalf-year Report
30th Aug 20223:24 pmRNSPublication of EGM Circular
29th Jul 20227:00 amRNSSale of La Zarza & Notice of EGM
27th Jun 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20227:00 amRNSFinal Results
24th Dec 20211:19 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSAppointment of CEO
19th Nov 20217:00 amRNSGrant of Options
4th Oct 20217:00 amRNSBoard Roles and Disclosures for New Directors
30th Sep 20213:29 pmRNSResult of AGM
23rd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAGM Update
14th Jul 20217:00 amRNSAdjourned AGM
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:05 pmRNSSecond Price Monitoring Extn
1st Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20219:50 amRNSAGM Update
29th Jun 20217:00 amRNSAGM - Director Requisitions
24th Jun 20214:40 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSAnnual Report & Notice of AGM
26th May 20217:00 amRNSHolding(s) in Company
26th May 20217:00 amRNSFinal Results
7th Apr 20219:05 amRNSSecond Price Monitoring Extn
7th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:43 pmRNSUpdate on Acquisition
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
12th Mar 20215:00 pmRNSUpdate on Migration
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.